Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
-8.6
EBITDA前年同期比（％）Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFirst quarter of the fiscal year ending September 202610 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥12,936 million+9.9%
Operating profit¥1,597 million-20.5%
Net income¥1,081 million-19.7%
Operating profit margin12.3 %
Results for the three months of the current quarter
Net Sales
¥12,936 million
EBITDA
¥2,399 million
Operating profit
¥1,597 million
Net income for the current fiscal year
¥1,081 million
Full-year earnings forecast
Net Sales
¥51,700 million
EBITDA
¥7,100 million
Operating profit
¥3,800 million
Net income for the current fiscal year
¥2,100 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales25.0%
EBITDA33.8%
Operating profit42.1%
Net income for the current fiscal year51.5%
医心館事業_売上高25.0%
医心館事業_EBITDA37.1%
医心館事業_セグメント利益50.3%
総合医療支援事業_売上高23.5%
総合医療支援事業_引当前営業利益23.0%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
On trackBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Change in revenue from existing facilities¥-253 million
Increase in personnel expenses at existing facilities (cost of sales)¥-125 million
Revenue increase from new facilities¥1,246 million
Increase in personnel expenses at new facilities (cost of sales)¥-731 million
Increase in land rents and rent expenses (cost of sales)¥-92 million
Increase in personnel expenses (SG&A)¥-41 million
Other¥-228 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Opening plan9 facilities
新規開設定員数526名
Operating conditionsExpected to recover gradually toward the end of the fiscal year
Medical fee revisionThe impact of the fiscal 2026 medical fee revision is reflected to a certain extent
Personnel expenses, etc.インフレ影響等を考慮し増加する計画
New initiatives
- 総合医療支援事業を新たなセグメントとして切り出し
- 新たに1つの医療機関への支援を決定
- 医療機関支援で経営コンサル・金融支援・商社機能の3メニューを展開
- 新たな情報共有ツール『TUNAG』を導入
- 自社建築以外のリース、M&A、中古物件、不動産流動化、不動産建築受託など多様な開設スキームを活用
Key KPIsA metric the company considers important as a management benchmark.
- Occupancy rate at existing facilities75.9 %
- Occupancy rate at new facilities35.7 %
- Percentage of end-of-life care provided in facilities98.9 %
- NPS57.1 Points
- Average customer satisfaction8.8 out of 10
- 看護師比率99.3 %
Segment results
Ishinkan (medical care housing) business
Net Sales
¥12,737 million+9.2%
EBITDA
¥2,410 million-7.8%
Segment profit
¥1,608 million-19.6%
Comprehensive Medical Support Business
Net Sales
¥200 million+90.3%
Operating profit before provisions
¥138 million+96.5%
Segment profit
¥-10 million
Financial targets
Target equity ratio30%
Market Size / Share
- 日本のがん死亡者数Scale約40万人
- 日本の病院病床数Scale150万床
- 医心館が受け入れるがん患者の国内比率2.1 %
Number of stores and locations
Number of facilities at period end134 Facility
Facilities opened during the period4 Facility
Capacity6,917 Facility
Capacity unitPeople
Annual Dividend
Annual dividend per share
¥4
Year-end dividend
¥4
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending September 2026 |
| Net Sales | ¥12,936 million (YoY +9.9%) |
| Operating profit | ¥1,597 million (YoY -20.5%) |
| Net income | ¥1,081 million (YoY -19.7%) |
| Operating profit margin | 12.3 % |
| Results for the three months of the current quarter | Net Sales ¥12,936 million / EBITDA ¥2,399 million / Operating profit ¥1,597 million / Net income for the current fiscal year ¥1,081 million |
| Full-year earnings forecast | Net Sales ¥51,700 million / EBITDA ¥7,100 million / Operating profit ¥3,800 million / Net income for the current fiscal year ¥2,100 million |
| Progress against full-year forecast | Net Sales 25.0% / EBITDA 33.8% / Operating profit 42.1% / Net income for the current fiscal year 51.5% / 医心館事業_売上高 25.0% / 医心館事業_EBITDA 37.1% / 医心館事業_セグメント利益 50.3% / 総合医療支援事業_売上高 23.5% / 総合医療支援事業_引当前営業利益 23.0% |
| Self-assessment against the plan | On track |
| Segment results | Ishinkan (medical care housing) business Net Sales ¥12,737 million (YoY +9.2%) / EBITDA ¥2,410 million (YoY -7.8%) / Segment profit ¥1,608 million (YoY -19.6%) / Comprehensive Medical Support Business Net Sales ¥200 million (YoY +90.3%) / Operating profit before provisions ¥138 million (YoY +96.5%) / Segment profit ¥-10 million |
| Breakdown of Factors Affecting the Change | Change in revenue from existing facilities ¥-253 million / Increase in personnel expenses at existing facilities (cost of sales) ¥-125 million / Revenue increase from new facilities ¥1,246 million / Increase in personnel expenses at new facilities (cost of sales) ¥-731 million / Increase in land rents and rent expenses (cost of sales) ¥-92 million / Increase in personnel expenses (SG&A) ¥-41 million / Other ¥-228 million |
| Key KPIs | Indicator name Occupancy rate at existing facilities / Value 75.9 % / Year on year against the same period last year Not disclosed, Indicator name Occupancy rate at new facilities / Value 35.7 % / Year on year against the same period last year Not disclosed, Indicator name Percentage of end-of-life care provided in facilities / Value 98.9 % / Year on year against the same period last year Not disclosed, Indicator name NPS / Value 57.1 Points / Year on year against the same period last year Not disclosed, Indicator name Average customer satisfaction / Value 8.8 out of 10 / Year on year against the same period last year Not disclosed, Indicator name 看護師比率 / Value 99.3 % / Year on year against the same period last year Not disclosed |
| Number of stores and locations | Number of facilities at period end 134 Facility / Facilities opened during the period 4 Facility / 期中閉鎖数 Not disclosed / Capacity 6,917 Facility / Capacity unit People |
| Assumptions Underlying the Business Outlook | Opening plan 9 facilities / 新規開設定員数 526名 / Operating conditions Expected to recover gradually toward the end of the fiscal year / Medical fee revision The impact of the fiscal 2026 medical fee revision is reflected to a certain extent / Personnel expenses, etc. インフレ影響等を考慮し増加する計画 |
| Financial targets | Target equity ratio 30% |
| Annual Dividend | Annual dividend per share ¥4 / Interim Dividend Not disclosed / Year-end dividend ¥4 |
| Market Size / Share | Subject 日本のがん死亡者数 / Scale 約40万人, Subject 日本の病院病床数 / Scale 150万床, Subject 医心館が受け入れるがん患者の国内比率 / Value 2.1 % |
| New initiatives | 総合医療支援事業を新たなセグメントとして切り出し, 新たに1つの医療機関への支援を決定, 医療機関支援で経営コンサル・金融支援・商社機能の3メニューを展開, 新たな情報共有ツール『TUNAG』を導入, 自社建築以外のリース、M&A、中古物件、不動産流動化、不動産建築受託など多様な開設スキームを活用 |
Items this document does not state (12)
Ordinary incomeGross Profit MarginSelling, general and administrative expensesUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.施設の開設と立ち上がりにより増収となった一方、施設稼働率の一時的な低下とシフトチェンジによる人件費上昇によりEBITDAが減少した。総合医療支援事業では、一部取引先について予防的に貸倒引当金を計上した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.